Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Retained Earnings of -$128000.0 in Q1 2026, up 99.99% quarter-over-quarter from -$1.0 billion in Q4 2025, and up 99.99% on a YoY basis from -$64003.0 in Q1 2025.
Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$128000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.99% year-over-year to -$128000.0; the TTM figure through Mar 2026 stood at -$128000.0 (up 99.99% YoY), while the FY2025 annual figure was -$1.0 billion, down 10230510.0% from the prior year.
- Retained Earnings was -$128000.0 for Q1 2026 at Rigel Pharmaceuticals, up from -$1.0 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $96000.0 in Q3 2025 to a low of -$1.4 billion in Q2 2024.
- Historically, Retained Earnings has averaged -$717.8 million across 5 years, with a median of -$1.0 billion in 2025.
- Biggest YoY gain for Retained Earnings was 100.01% in 2025; the steepest drop was 10230510.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$153000.0 in 2022, then tumbled by 919867.32% to -$1.4 billion in 2023, then soared by 100.0% to $10000.0 in 2024, then tumbled by 10230510.0% to -$1.0 billion in 2025, then soared by 99.99% to -$128000.0 in 2026.
- The last three Retained Earnings figures came in at -$128000.0 (Q1 2026), -$1.0 billion (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | -128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -1.38 Bn |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | -1.41 Bn |
| Sep 30, 2023 | -1.41 Bn |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -1.40 Bn |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -286,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -1.35 Bn |
| Dec 31, 2021 | -1.32 Bn |
| Sep 30, 2021 | -1.30 Bn |
| Jun 30, 2021 | -1.28 Bn |